Impact of prostate volume on the efficacy of high-power Potassium-titanyl-phosphate photoselective vaporization of the Prostate: A Retrospective, Short-Term Follow-Up study on evaluating feasibility and safety

Yonsei Medical Journal

Volumn 51, Issue 6, 2010, Pages 877-882

  Ku, Ja Hyeon ^a   Kim, Soo Woong ^a   Paick, Jae Seung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Benign prostatic hyperplasia; KTP; Laser surgery; Prostate; Vaporization

Indexed keywords

PHOSPHATE; POTASSIUM; TITANIUM DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EVALUATION; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTVOID RESIDUAL URINE VOLUME; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; SAFETY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT DISEASE; URINE FLOW RATE; VAPORIZATION;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PHOSPHATES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; TITANIUM; TREATMENT OUTCOME; URINARY TRACT; VOLATILIZATION;

EID: 77957943156     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.6.877     Document Type: Article

References (29)

1. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-6.
2. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;72:1404-8.
3. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9.
4. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004;18:976-81.
5. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
6. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173: 158-60.
7. Kumar SM. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005;173:511-3.
8. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassiumtitanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174: 1344-8.
9. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Müller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005;47:798-804.
10. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, et al. Short term outcomes of high power (80 W) potassium-titanylphosphate laser vaporization of the prostate. Eur Urol 2005;48: 608-13.
11. Sarica K, Alkan E, Lüleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005;19:1199-202.
12. Barber NJ, Zhu G, Donohue JF, Thompson PM, Walsh K, Muir GH. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 2006;67:80-3.
13. Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Urology 2006;68:312-7.
14. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006;97:1229-33.
15. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5.
16. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP, et al. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006;8:367-71.
17. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassiumtitanyl- phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996;48:575- 83.
18. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Highpower (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997;49:703-8.
19. Lee R, Saini R, Zoltan E, Te AE. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol 2008;180:1551-3.
20. Spaliviero M, Araki M. Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 2008;22: 2341-7.
21. Rieken M, Ebinger Mundorff N, Bonkat G, Wyler S, Bachmann A. Complications of laser prostatectomy: a review of recent data. World J Urol 2010;28:53-62.
22. Krambeck AE, Handa SE, Lingerman JE. Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol 2010;24:433-7.
23. Du C, Jin X, Bai F, Qiu Y. Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol 2008;22:1031-6.
24. Shingleton WB, Terrell F, Renfroe DL, Kolski JM, Fowler JE Jr. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999;54:1017-21.
25. Shingleton WB, Renfroe LD, Kolski JM, Fowler JE Jr. A randomized prospective study of transurethral electrovaporization vs. laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998;32:266-9.
26. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71.
27. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171:2502-4.
28. Paick JS, Um JM, Kim SW, Ku JH. Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 2007;4:1701-7.
29. Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate. Eur Urol 2009;55:1345-57.